Gardner Lewis Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,573
Closed -$946K 83
2021
Q4
$946K Buy
+3,573
New +$963K 0.18% 66

Other funds holding RGEN

Gardner Lewis Asset Management's RGEN Position: Q1 2022 in Review

Gardner Lewis Asset Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 3,573 shares — an estimated $946K sold.

Gardner Lewis Asset Management first reported a position in RGEN in Q4 2021 and held it in 1 quarter. The position peaked at $946K in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Gardner Lewis Asset Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 3,573 Repligen shares in Q1 2022, an estimated $946K.
  • Gardner Lewis Asset Management first reported a position in Repligen in Q4 2021 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Repligen position peaked at $946K in Q4 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2022, filed 11 May 2022.